Skip to content

Clinical trials

Observational Urinary Incontinence, Urge trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Incontinence, Urge Phase: Observational Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20102
20112
20121
20143
20151
20173
20182
20192
20204
20215
20223
20232
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Unknown status11
Terminated2
Recruiting2
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Axonics, Inc.2
Hospital Universitari Vall d'Hebron Research Institute2
National Taiwan University Hospital2
Al-Kindy College of Medicine1
Alexis Dieter1
Assiut University1
Avation Medical, Inc.1
Centre Hospitalier Universitaire de Saint Etienne1
Collegium Medicum w Bydgoszczy1
Gérard Amarenco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Incontinence, Urge40
Urinary Bladder, Overactive18
Urinary Incontinence, Stress15
Urinary Incontinence11
Pelvic Organ Prolapse6
Fecal Incontinence5
Lower Urinary Tract Symptoms5
Urinary Bladder, Neurogenic4
Multiple Sclerosis3
Urinary Retention3

Trials

Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.